Solna (Sweden) – Aerocrine AB (OMX Nordic Exchange: AERO) today announced that NICE (National Institute for Health and Care Excellence) has notified stakeholders that the final guidelines recommending the use of Aerocrine’s NIOX MINO® and NIOX VERO® to improve diagnosis and management of a type of asthma caused by airway inflammation are expected to be published in April. NICE develops evidence-based guidelines that help the National Health Services, local authorities and the wider medical community deliver high-quality healthcare to the British public. The new guidelines recommend that FeNO tests be used to assist with the diagnosis and management of asthma caused by allergic airway inflammation in adults and children who, after initial clinical examination, are considered to have an intermediate probability of having asthma and when FeNO testing is intended to be done in combination with other diagnostic options. Aerocrine’s NIOX MINO® and NIOX VERO® measure FeNO levels. Healthcare professionals use FeNO testing to identify allergic airway inflammation in patients with suspected asthma, to help predict patient response to corticosteroid therapy and to help assess patient adherence to the prescribed therapy. NIOX MINO and NIOX VERO produce reliable and accurate results and are built on the recommendations from the American Thoracic Society (ATS) and the European Respiratory Society (ERS). The Stakeholder Notification included the following information: The guidelines will look at how NIOX MINO and NIOX VERO technologies can improve diagnosis and management of asthma. The implementation pack, which includes case studies carried out in hospitals and GP surgeries, will provide useful information and practical advice on putting this guidance into practice. Respiratory clinicians from several NHS sites, who participated in the development of this pack, reported that benefits of adopting these technologies can include: · Reduced numbers of non-elective admissions associated with asthma · Reduced risk of readmission for patients admitted because of asthma after discharge from hospital · Improved and earlier diagnosis of asthma in adults and children · Reduced need for invasive lung function tests to diagnose or manage asthma · Ease of use for patients and suitably trained staff Aerocrine will provide additional information once the final guidelines are published according to the dates given by NICE. For more information, contact: Scott Myers, Chief Executive Officer, Aerocrine AB, Phone: +46 768 788 379, +970 368 0336 David Plotts, Vice President, UK Managing Director and EU/RoW Sales. +44 (0) 7891 433239 Dr. Kathy Rickard, Chief Medical Officer, Aerocrine AB +919 749 6708 About Aerocrine Aerocrine AB is a medical technology company focused on the improved management and care of patients with inflammatory airway diseases. As the pioneer and leader in technology to monitor and manage airway inflammation, Aerocrine markets NIOX MINO® and NIOX VERO® (EU) Both products enable fast and reliable management of airway inflammation and may therefore play a critical role in more effective diagnosis, treatment and follow-up of patients with inflammatory airway diseases such as asthma. Aerocrine is based in Sweden with subsidiaries in the U.S., Germany and the U.K. Aerocrine shares were listed on the Stockholm Stock Exchange in 2007. Aerocrine may be required to disclose the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 5:00 PM on 03/21/2014
NICE (UK) will support the use of Fractional exhaled
Top 10 Most Recent News Articles
Cognex Delivers Record Q3 Results, Eyes Future Growth
Shaking Up the Leaderboard with Record Revenues You want a testament to a well-oiled machine? Look no further than Cognex Corporation, flaunting a record quarterly revenue hitting $313 million. That's a hearty 13% uptick from last year. Peel back the layers, and excluding a one-time boon from a partnership last year, you're staring at a 19% year-over-year surge. Talk...
Continue Reading
REELZ Gears Up for 75th Miss Universe Pageant
A Global Celebration Comes to REELZ Let's dive straight into the glitz and spectacle—REELZ isn't just broadcasting some regular program. They're handing us the 75th Miss Universe pageant on a silver (or maybe gold, in this case) platter. Come November 24, at 8 PM ET, expect your screen to light up with beauty, culture, and a hefty dose of competition, as it unfolds live...
Continue Reading
Texas Alcohol Crash Stats Expose Reckless Drinking Scene
Staggering Numbers From Texas Crashes Reveal a Sobering Truth When you peel back the layers on Texas's latest alcohol-related crash data, you're looking at a grim picture painted by Grossman Law Offices. In a state that's no stranger to big numbers and even bigger drinks, finding that half of these crashes had a blood alcohol content (BAC) over twice the legal limit makes...
Continue Reading
Kyndryl and AWS Shake Up Enterprise Modernization
A New Dawn for Enterprise Modernization Modernizing enterprise infrastructure today ain't just about wading through outdated code lines. Kyndryl (NYSE: KD) is flipping the script, with their latest partnership with Amazon Web Services (AWS) aiming to make modernization swift, continuous, and AI-ready. Gone are the days of treating technology upgrades as a one-off event....
Continue Reading
Sae-A Trading Earns UNGC LEAD Recognition Again
Another Year, Another Win for Sae-A Trading When was the last time you heard of an apparel manufacturer making waves for the right reasons? Sae-A Trading, the outfit under the Global Sae-A Group banner, is strutting its sustainability stuff by getting named as a UNGC LEAD Company for the second straight year. You better believe that’s not just for show – they’ve got...
Continue Reading
Taiwan's Bold Bid: From Tech Hub to Capital Magnet
Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...
Continue Reading
RingConn Joins BVB Women's Team: Tech Meets Sport
Tech and Football: An Unlikely Alliance Alright, so here's a story that might perk your ears up—RingConn, a relative newcomer in the health tech world, has chosen to stake its future on a bet with Borussia Dortmund's women's football team. This isn't just your average brand-sponsorship slap-on-the-shirt deal; we're looking at a potential game-changer here, folks. Who...
Continue Reading
Elite Academy Takes Bold Step in Ethical AI for Schools
Pioneering New Fronts in Education with AI Elite Academic Academy, a stalwart in California's public charter school landscape, has just taken a significant stride forward by stepping into the EDSAFE AI Alliance District Policy Lab. The move, announced in early November 2026, sees Elite diving into the intricate world of artificial intelligence in education, with a pointed...
Continue Reading
Perpetua's Bold Moves Elevate Idaho's Stibnite Gold Project
Perpetua Resources Sparking New Conversations Alright, fasten your seatbelts, folks—Perpetua Resources is causing a buzz with its Stibnite Gold Project. If you blink, you might miss what's happening down in Idaho. They've started throwing some serious weight around with fresh gold discoveries that not only promise ounces but maybe some juicy returns for those keeping a...
Continue Reading
What Business Owners Need to Know About Glass Replacement
Understanding the Nuts and Bolts of Storefront Glass Replacement Picture your storefront beaten and battered, glass cracks spidering over once-pristine panes. Cue Matt Sears of Bentonville Glass Inc. ready to patch things up without turning your business into a disaster zone. The homegrown hero makes his debut in HelloNation's latest chat, offering the kind of advice you...
Continue ReadingTop 5 Most Recently Viewed Articles
Piramal Pharma and NewAmsterdam's Joint Venture for OSD Suite
Strategic Investment to Boost Pharmaceutical Production Piramal Pharma Solutions and NewAmsterdam Pharma Company N.V. have embarked on an ambitious project to enhance their oral solid dosage (OSD) capabilities. This new dedication to pharmaceutical manufacturing illustrates their commitment to meeting rising healthcare demands. The multi-million-dollar investment seeks to...
Continue Reading
Dynacor Group Announces Upcoming Dividend and Insights
Dynacor Group Announces Upcoming Dividend Dynacor Group Inc. (TSX: DNG) has declared its monthly dividend for October, an essential aspect for shareholders. The company will distribute C$0.01333 per common share, with payment scheduled for October 16 to those holding shares by the close of business on October 9. This marks the 67th dividend the corporation has provided....
Continue Reading
Danske Bank's Buy-Back Program: Week 2 Summary and Insights
Danske Bank's Buy-Back Program Overview Danske Bank A/S has initiated an impressive share buy-back program aimed at enhancing shareholder value. This program, set for a total of DKK 5.5 billion, encompasses the repurchase of up to 70 million shares. It commenced on February 5, 2024, and is designated to conclude by January 31, 2025. This substantial commitment was...
Continue Reading
Howmet Aerospace: A Promising Investment Journey Over Five Years
Howmet Aerospace's Investment Potential Howmet Aerospace (NYSE: HWM) has shown remarkable performance, significantly exceeding market averages over the past five years. Investors who have been with the company through this period are likely quite satisfied with their returns. The annualized return of 51.59% speaks volumes about the company's strategic growth and...
Continue Reading
Recent Updates on Investment Fund Wealth Invest's Prospectuses
Updates on Wealth Invest Prospectuses We are pleased to announce the recent updates to the prospectuses for the listed departments within the investment fund Wealth Invest. These changes reflect the fund's commitment to maintaining transparency and enhancing investor confidence. Reason for Updates The prospectuses have undergone revisions primarily due to a name change...
Continue Reading